Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Audio By Carbonatix

PRINCETON, N.J.--(BUSINESS WIRE)--Aug 29, 2025--

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Morgan Stanley 23 rd Annual Global Healthcare Conference on Monday, September 8, 2025.

The company will take part in a fireside chat beginning at 8:30 a.m. ET.

Investors and the general public are invited to listen to the session by visiting http://investor.bms.com. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb: Transforming Patients’ Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what’s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

View source version on businesswire.com:https://www.businesswire.com/news/home/20250829005040/en/

CONTACT: Media Relations:

[email protected]

Investor Relations:

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY

SOURCE: Bristol Myers Squibb

Copyright Business Wire 2025.

PUB: 08/29/2025 06:59 AM/DISC: 08/29/2025 07:00 AM

http://www.businesswire.com/news/home/20250829005040/en